Effective Endurance Training in Metabolic Syndrome | NCT00218998

Studies
Effective Endurance Training in Metabolic Syndrome

NCT00218998

Sponsor

Norwegian University of Science and Technology

Status

Completed

Last Update Posted

Dec 29, 2023Actual

Enrollment

30Estimated

Phase

Not Applicable

Conditions

Impaired Glucose Tolerance
Overweight
Hypertension
Dyslipidemia

Interventions

exercise training

Countries

Norway

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Dec 2023

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Jan 2004Actual

Primary Completion Date

Not provided

Completion Date

Not provided

First Submitted Date

Sep 20, 2005

First Submission Date that Met QC Criteria

Sep 20, 2005

First Posted Date

Sep 22, 2005Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Dec 28, 2023

Last Update Posted Date

Dec 29, 2023Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Design Module

Study Type

Interventional

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not Applicable

Interventional Study Design

Allocation

Biospecimen

No data available

No data is available for this block.

Enrollment

30Estimated

Name	Type	Description	Arm Group Labels	Other Names
exercise training	Behavioral

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
To reduce risk factors related to metabolic syndrome

Secondary Outcomes

Measure	Description	Time Frame
Improve endothelial functions in patient with metabolic syndrome

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

insulin resistance, impaired glucose tolerance or type 2-diabetes, including two or more of the following factors: Blood pressure ≥ 140/90 mm Hg, Triglycerides Fasting ≥ 1,7 mmol/l, and/or low HDL-cholesterol (≤ 0,9 mmol/l in men, ≤ 1,0 mmol/l in women)
Obesity, Waist-hip ratio ≥ 0,9 in men, ≥ 0,85 in women or BMI (body mass index) ≥ 30 kg/m2
Microalbuminuria (albumin secretion ≥ 20 mg/l or 20 - 200 g per minute)

Exclusion Criteria:

Accepts Healthy Volunteers

Not provided

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

20 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

Not provided

Sampling Method

Not provided

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Ulrik E Wisløff, Phd prof	National Taiwan Normal University	Study Chair

Locations

Facility	Status	City	State	ZIP	Country	Contacts
The medical faculty at norwegian university of science and technology		Trondheim		7489	Norway

References Module

Citations

PubMed Identifier	Type	Citation	Retractions
19255350	Background	Poelkens F, Hopman MT, Tack CC. Letter by Poelkens et al regarding article, "Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study". Circulation. 2009 Mar 3;119(8):e225; author reply e226. doi: 10.1161/CIRCULATIONAHA.108.818765. No abstract available.
18606913	Result

ID	Term
D018149	Glucose Intolerance
D050177	Overweight
D006973	Hypertension
D050171	Dyslipidemias
D009043	Motor Activity

ID	Term
D006943	Hyperglycemia
D044882	Glucose Metabolism Disorders
D008659	Metabolic Diseases
D009750	Nutritional and Metabolic Diseases

ID	Term
D009043	Motor Activity
D009068	Movement
D009142	Musculoskeletal Physiological Phenomena
D055687	Musculoskeletal and Neural Physiological Phenomena